India's Aarti Drugs up after getting GMP certification
** Shares of drugmaker Aarti Drugs ADRG.NS rise 2% to 525
rupees
** Co said UK's Medicines and Healthcare products Regulatory
Agency issued GMP compliance certificate for unit's
manufacturing facility in Himachal Pradesh
** Stock set to snap four straight weeks of losses, gained
~2% this week
** Stock has risen 7.7% YTD
(Reporting by Yagnoseni Das in Bengaluru)
((Yagnoseni.Das@thomsonreuters.com;))
Recent news on Aarti Drugs
See all newsBrief: Aarti Drugs Says Adhish P. Patil Appointed MD For 5 Years From Oct 1
Brief: Aarti Drugs Posts June-Qtr Consol Net Profit 501.7 Million Rupees
Brief: Aarti Drugs March-Quarter Consol Profit 552.6 Million Rupees
Brief: Aarti Drugs Dividend 2 Rupees Per Share
Brief: Aarti Drugs Dec-Quarter Consol Net Profit 405.4 Million Rupees